Showing 1,121 - 1,140 results of 101,509 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (mean decrease)) ))', query time: 1.51s Refine Results
  1. 1121

    (R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

    Published 2011
    “…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”
  2. 1122

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  3. 1123
  4. 1124

    Spatial training decreases the association between Ndfip1 and Nedd4 and decreases endogenous Beclin 1 ubiquitination in the hippocampus. by Wei-Lun Hsu (1756123)

    Published 2023
    “…Endogenous Beclin 1 ubiquitination level is decreased in Nedd4 siRNA-transfected rats (t<sub>1,6</sub> = 5.78, <i>p</i> = 0.001). …”
  5. 1125

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…CRT in the recurrence group significantly decreased from 546.1 ± 117.0 μm preoperatively to 317.1 ± 46.9, 317.8 ± 55.6, 290.8 ± 33.5, 342.9 ± 82.2, 333.0 ± 84.2, and 349.8 ± 76.9 μm at 1, 3, 6, 12, 24, and 36 months postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
  6. 1126
  7. 1127
  8. 1128
  9. 1129
  10. 1130
  11. 1131

    Expression of SPDEF in TRAMP C2 prostate adenocarcinoma cells decreased cell growth, reduced migration and colony formation on soft agar. by Xin-Hua Cheng (154368)

    Published 2014
    “…Control and SPDEF-expressed TRAMP C2 cells were seeded in triplicates and counted at different time points using hemocytometer. <b>C</b>. Overexpression of SPDEF decreased migration of TRAMP C2 adenocarcinoma cells <i>in vitro</i>. …”
  12. 1132
  13. 1133
  14. 1134
  15. 1135
  16. 1136

    (R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”
  17. 1137

    (R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”
  18. 1138

    Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

    Published 2016
    “…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”
  19. 1139

    Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

    Published 2016
    “…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”
  20. 1140